SELECT SECTOR

PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS

Bernardo Estupiñán
MANAGING DIRECTOR, CDMO ADVISOR
"What used to take months—finding a CDMO, verifying capabilities, reaching the right contact—can now be done in minutes."
United States
Pharma & Life Sciences
Saurabh Gurnurkar
MANAGING DIRECTOR, UQUIFA GROUP
"The preference for European manufacturers in the US has grown over the past five or six years, driven by the push for geopolitical risk mitigation."
United States
Pharma & Life Sciences
Ben Bradford
HEAD OF EXTERNAL AFFAIRS, MASSBIO
"It is the Massachusetts story — early-stage companies developing great science, commercial giants with a local presence, and financial partnerships that turn ideas into treatments."
United States
Pharma & Life Sciences
Tim Scott
PRESIDENT AND CEO, BIOCOM CALIFORNIA
"We have recognized the synergies between the life science and tech industries, and have worked to foster relationships that can accelerate therapeutic, medical device and diagnostic development."
United States
Pharma & Life Sciences

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Québec and Atlantic Canada Mining 2025

Québec and Atlantic Canada have traversed 2025 in an enviable position. Strong gold prices have buoyed balance sheets and investor sentiment, while global demand for critical minerals keeps the region firmly on the radar of international markets. At the same time, the provinces’ depth of mining expertise – from AI-driven exploration to advanced drilling, blasting, and geophysics – ensures that technological advantage is firmly on their side.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL